K

KeyMed Biosciences Inc
HKEX:2162

Watchlist Manager
KeyMed Biosciences Inc
HKEX:2162
Watchlist
Price: 40.4 HKD -2.42% Market Closed
Market Cap: 11.1B HKD
Have any thoughts about
KeyMed Biosciences Inc?
Write Note

KeyMed Biosciences Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

KeyMed Biosciences Inc
Cash from Investing Activities Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
K
KeyMed Biosciences Inc
HKEX:2162
Cash from Investing Activities
ÂĄ468.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Investing Activities
ÂĄ117.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Investing Activities
-ÂĄ2.1B
CAGR 3-Years
-91%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash from Investing Activities
-ÂĄ1.2B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
-30%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Investing Activities
-ÂĄ837.9m
CAGR 3-Years
21%
CAGR 5-Years
-18%
CAGR 10-Years
-12%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Investing Activities
-ÂĄ1.3B
CAGR 3-Years
-12%
CAGR 5-Years
-102%
CAGR 10-Years
N/A

See Also

What is KeyMed Biosciences Inc's Cash from Investing Activities?
Cash from Investing Activities
468.2m CNY

Based on the financial report for Dec 31, 2023, KeyMed Biosciences Inc's Cash from Investing Activities amounts to 468.2m CNY.

Back to Top